Ren Patrick Jolly, PA-C

Ren Jolly practices at Tallahassee Outpatient Surgery Center in Tallahassee, Florida.

Ren Jolly's NPI, 1780052498, was assigned on September 11, 2015. Ren Jolly holds Florida license PA9109002.

Ren Jolly's primary practice is Tallahassee Outpatient Surgery Center, at 3334 Capital Medical Blvd, Ste 500, Tallahassee, FL 32308. The practice phone is (904) 877-4688.

Ren Jolly's primary practice is Tallahassee Outpatient Surgery Center in Tallahassee, Florida. The medical group on file is Tallahassee Orthopedic Clinic. Dmand AI also links Ren Jolly to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ren Jolly practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Ren Jolly's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Ren Jolly is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Ren Jolly is licensed in Florida.

Dmand AI lists arthritis, carpal tunnel syndrome, fibromyalgia and chronic pain, joint pain, knee injury, lower back pain, minor injury to a limb and muscle pain, fibromyalgia, and limb pain among the conditions Ren Jolly treats.

CMS data shows 60,825 Medicare services from Ren Jolly across 18 procedure codes in 2024, for 588 Medicare patients. Medicare paid $208,201 for them. Every service was in an office.

CMS counts 588 Medicare patients who saw Ren Jolly in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ren Jolly's median patient age at 71, with 57% women.

In 2024, Ren Jolly wrote 766 Medicare Part D claims for 252 patients. 98% of them were for generic drugs. CMS names the drug for 721 of them, across 10 drugs with 11 or more claims each, at $10,312 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Ren Jolly for performance year 2024, reported as part of a group. Ren Jolly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Ren Jolly from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $176.